Is BA.2, Omicron subvariant disarming key antibody treatment?
According to a report published in the journal Nature, while US health regulators added a new antibody drug to the country’s arsenal against the Omicron variant of coronavirus, the rapidly spreading subvariant, BA.2, may force doctors to reconsider an...
24 February, 2022
Read more